Osteitis

12/01/2001 - "Intravenous pamidronate may constitute a safe and effective treatment option for patients with refractory osteitis pubis."
07/04/2019 - "Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity."
07/04/2019 - "To study the response to pamidronate using whole body magnetic resonance imaging (WB-MRI) in children with chronic non-bacterial osteitis (CNO) in a tertiary health centre. "
01/12/2009 - "Pamidronate treatment was continued until resolution of MRI documented bone inflammation. "
11/01/2014 - "The aim of this study was to describe the efficacy of pamidronate therapy on disease activity in children with chronic non-bacterial osteitis (CNO) using whole body MRI (WB-MRI). "

08/03/1989 - "We conclude that long-term intermittent infusions of intravenous calcitriol are effective in ameliorating osteitis fibrosa in patients on dialysis. "
12/28/1989 - "Calcitriol for osteitis fibrosa."
01/01/1996 - "The use of high-dose pulse intravenous, intraperitoneal, and oral calcitriol therapy has significantly decreased serum PTH levels and retarded the progression of osteitis fibrosa. "
01/01/1995 - "Intravenous calcitriol can increase bone mass in hemodialysis patients with osteitis fibrosa."
11/01/1982 - "[Treatment of osteitis fibrosa with 1,25-dihydroxycholecalciferol in patients in treatment with periodic hemodialysis. "

01/06/2023 - "Regional antibiotic perfusion through the lateral saphenous vein in two horses with septic calcaneal osteitis."
06/01/2017 - "Corrective trimming, topical treatments, and an oral antibiotic resulted in apparent resolution; however, it reoccurred after 4 mo. Radiographs suggested bone lysis in the third phalanx, with the primary differential diagnosis being septic osteitis. "
05/01/2013 - "Osteitis has been treated both with intravenous antibiotics and surgery. "
10/09/2009 - "The erythrocyte sedimentation rate was determined and a MRI (of the osteitis lesion, radiologic activity score from 0 to 2) was performed in week 1 (W1), week 16 (W16), and week 28 (W28, 12 weeks after antibiotics). "
01/01/2008 - "The antibiotics certainly revolutionized the treatment of the osteitis but their use must be more discriminatory based on a very precise antibiogramm. "

03/01/2000 - "In conclusion, intravenous OCT effectively suppressed PTH secretion and improved the bone histological characteristics of severe osteitis fibrosa, especially in patients with initial serum calcium levels less than 10 mg/dL. "
11/01/2022 - "We want to emphasize the inclusion of osteitis fibrosa cystic in the differential diagnosis of osteolytic lesions and the need to perform serum calcium and PTH measurements when investigating these lesions."
10/01/2000 - "Although bone biopsy represents the definitive diagnostic test to differentiate between osteitis fibrosa, low-turnover bone disease and bone involvement unrelated to disturbed calcium metabolism (i.e. "
07/01/2000 - "Although bone biopsy represents the definitive diagnostic test to differentiate between osteitis fibrosa, low-turnover bone disease and bone involvement unrelated to disturbed calcium metabolism (i.e. "
11/01/1979 - "Doses of 25-OHD3 capable to correct blood calcium levels and intestinal absorption of calcium, may have minimal benefit on the osteitis fibrosa component of the bone lesion."

05/01/2015 - "Furthermore, the osteitis score decreased significantly during the 12-months' follow-up in the adalimumab group, but not in the placebo group, Wilcoxon: p=0.001-0.002 and p=0.062-0.146. "
02/15/2023 - "Adalimumab treatment was effective in treating both osteitis and retinal vasculitis."
02/01/2012 - "Despite maintenance of clinical remission, follow-up imaging studies after 24 months of adalimumab monotherapy revealed osteoarticular disease progression, with features of inflammatory osteitis. "
05/01/2015 - "The findings suggest that addition of adalimumab is associated with further suppression of osteitis and tenosynovitis."
01/01/2017 - "We report on a 45-year-old Japanese female with Crohn's disease developing SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome following exposure to the anti-TNFα antibody adalimumab. "

11/01/2016 - "In this context, we investigated the impact of the distinct components, including synovial inflammation, bone erosion or cartilage damage, as well as the effect of blocking tumor necrosis factor (TNF) on functional impairment in human-TNF transgenic (hTNFtg) mice, a chronic inflammatory erosive animal model of RA. "
09/01/2020 - "Paradoxical adverse events in the oral cavity caused by anti-tumor necrosis factor-α therapy for pustulotic arthro-osteitis."
05/01/2004 - "In this study, these propositions were tested in two experiments by instilling IL-1beta or TNF-alpha into one knee of Lewis rats (n = 6/group) to incite arthritis, after which semiquantitative scores for inflammation, bone resorption, osteoclasts, and cartilage integrity were acquired. "
04/01/2008 - "We describe 2 new cases with ilium osteitis as the main SAPHO syndrome feature and review reported cases treated with anti-TNF-alpha. "
01/01/2008 - "Recent data about radiographic progression during treatment with tumor necrosis factor-alpha (TNF-alpha) blocker agents in patients with ankylosing spondylitis (AS) have prompted an intensive discussion about the link between inflammation/bone destruction and new bone formation and the order of events. "

04/11/1950 - "[Osteitis fibrosa generalisata with epithelial body tumor after a prolonged period of AT-10 dosage]."
05/01/1983 - "Dihydrotachysterol seems to be effective in the treatment of renal patients with osteitis fibrosa; its low cost makes therapy with this compound a reasonable alternative, although it should not be used in the treatment of patients with liver disease. "
06/22/1974 - " the absence of fluoride, although osteitis fibrosa occurred, it was reversible in 10 out of 12 cases by dihydrotachysterol treatment, and overall there was no evidence of progression of bone disease at the end of the study period."
06/01/1979 - "Administration of dihydrotachysterol and 1 alpha-hydroxycholecalciferol to the patients on hemodialysis changed the mixed type of osteomalacia and osteitis fibrosa to the osteomalacic type with the marked reduction of osteoid seam thickness."
01/01/1984 - "The prevention and therapy of osteitis fibrosa and secondary hyperparathyroidism have been significantly improved as a result of adequate phosphate restriction and the use of active forms of vitamin D (primarily calcitriol in the U.S., dihydrotachysterol and 1 alpha-hydroxyvitamin D in Europe). "

11/01/2011 - "Golimumab plus MTX significantly improved MRI-detected synovitis and osteitis (prognosticators of future structural damage) versus placebo plus MTX at weeks 12 and 24. "
11/01/2011 - "Significant improvements in synovitis and bone oedema (osteitis) were observed in the combined golimumab plus MTX groups versus placebo plus MTX at week 12 (-1.77 vs -0.15, p<0.001 wrist+MCP and -2.00 vs 0.19, p=0.003, respectively) and week 24 (-1.91 vs -0.38, p<0.001 wrist+MCP and -1.74 vs 0.71, p=0.004, respectively). "
12/01/2011 - "At weeks 12 and 24, combined therapy with golimumab plus MTX versus placebo plus MTX significantly improved RAMRIS scores for synovitis (mean -1.92 versus 0.14 [P < 0.001] at week 12; -2.45 versus -1.04 [P < 0.001] at week 24), osteitis (mean -1.82 versus 0.56 [P < 0.001] at week 12; -2.27 versus -0.32 [P < 0.001] at week 24), and bone erosion (mean -0.40 versus 0.24 [P = 0.016] at week 12; -0.40 versus -0.24 [P = 0.010] at week 24). "
12/01/2011 - "Improvements in inflammation (synovitis and osteitis) and erosions with golimumab plus MTX therapy exceeded those with placebo plus MTX therapy from week 12 onward, confirming the overall clinical/radiologic findings. "
12/01/2011 - "Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients."

01/01/1979 - "Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis."
06/01/1977 - "Treatment should involve prompt surgical repair and reversal of the osteitis fibrosa with an effective vitamin D metabolite such as 1alphaOHD3."
01/01/2009 - "In the past few years, research has revealed new and mostly unsuspected roles for SXR in modulating inflammation, bone homeostasis, vitamin D metabolism, lipid homeostasis, energy homeostasis and cancer. "
11/01/2002 - "In contrast, osteitis fibrosa and parathyroid tumor weight changed very little in parts of the world where vitamin D depletion is endemic. "
11/01/2002 - "Between 1945 and 1950, both the prevalence of osteitis fibrosa and parathyroid tumor weight declined dramatically in the United States, coinciding with fortification of milk with vitamin D. "

12/10/1946 - "Severe osteitis of the iliac wing cured by massive doses of penicillin."
01/01/1952 - "The penicillin treatment of acute haematogenous osteitis: a review of some unsatisfactory results."
06/25/1948 - "Penicillin-treated osteitis in the forehead."
02/01/1948 - "Haematogenous osteitis in children; preliminary report on treatment with penicillin."
09/01/1953 - "[Penicillin therapy of hematogenic infectious osteitis]."

01/01/2018 - "This study evaluates the importance of HBO in an early implant-associated localized osteitis caused by Staphylococcus aureus (SA) compared to the standard therapy. "
02/01/1989 - "The following study reports the frequency, the promoting factors, the therapy and her results of the 32 patients with posttraumatic osteitis we treated between 1984 and 1986 in the Surgical University Clinic Tübingen. "
01/01/2020 - "Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant."
01/01/2019 - "Herein we report a series of cases demonstrating the emergence of severe SpA-associated enthesitis/osteitis following successful IBD therapy with VDZ. "
06/01/2017 - "Non-surgical therapy is successful in treating pubic overload and osteitis pubis in athletes. "

12/01/1998 - "In summary, cases having undergone hemodialysis more than 10 years showed higher frequency of osteitis fibrosa when intact-PTH exceeded 500 pg/ml. Al-P values in such cases were high in association with the intact-PTH values. "
11/01/1992 - "[Hormonal markers of early-stage osteitis fibrosa in patients on hemodialysis]."
02/01/1990 - "I-PTH levels were well correlated with the severity of osteitis fibrosa evaluated by the degree of periosteal resorption in the digits of hemodialysis patients. "
11/01/1986 - "In conclusion, these data suggest that a PTH RIA that uses an amino-terminal-specific antiserum may be a better predictor of osteitis fibrosa in patients undergoing maintenance hemodialysis."
10/08/1977 - "DHT, in doses of up to 1.0 mg/d, is effective in treating both the osteitis fibrosa and the osteomalacic components of bone disease in patients undergoing hemodialysis."

02/01/2020 - "Prognostic Factors and Long-Term Efficacy of Tonsillectomy in 17 Patients with Pustulotic Arthro-Osteitis."
02/01/2020 - "In this case study, we aimed to evaluate the disease condition of patients with pustulotic arthro-osteitis (PAO) at 36-month post-tonsillectomy. "
07/01/2018 - "Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients."
06/01/2008 - "In patients that had undergone a tonsillectomy or dental treatment, the clinical activities of PPP, both the skin lesions and pustulotic arthro-osteitis were followed for over 2 years. "
02/01/1999 - "Cervicovertebral osteitis: a complication of uvulopalatopharyngoplasty with tonsillectomy."

06/01/1985 - "However, despite marked improvement in subperiosteal erosions and histological osteitis fibrosa, with significant reductions in iPTH and Ca X P product after parathyroidectomy, small peripheral arterial calcification developed or progressed in 56 per cent of the patients. "
01/01/1996 - "Patients with high carboxyl-terminal PTH level and generalized fibrous osteitis were good suitable objects for parathyroidectomy. "
11/01/1995 - "The latter showed osteitis fibrosa, and the patient underwent parathyroidectomy. "
10/01/1991 - "Serum ALP and PTH level and the presence of generalized fibrous osteitis were good indicators for parathyroidectomy. "
04/01/1988 - "Six years before this terminal illness he had undergone total parathyroidectomy for osteitis fibrosa associated with ruptured tendons. "

09/01/2015 - "Open curettage of the symphysis has shown promising results in patients with recalcitrant osteitis pubis. "
01/01/2008 - "Patients met the criteria for the study if they had symptoms suggestive of osteitis pubis and underwent isolated pubic symphysis curettage. "
01/01/2018 - "Currently described surgical interventions, although limited, include plating, which provides an overly rigid construct with the risk of failure and possibly poor long-term outcomes particularly in athletes, and treatments such as curettage, more commonly used in the treatment of osteitis pubis. "
06/01/2015 - "Endoscopic pubic symphysectomy was developed as a less invasive option than open surgical curettage for recalcitrant osteitis pubis. "
01/01/2008 - "Curettage of the pubic symphysis is a viable option for nonoperative treatment of resistant osteitis pubis in athletes. "